EichorEICHOR
Condition: L Arginine Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: L Arginine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Sho
Phase 3 · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT07063680An Exploratory Physiological Study of Post-operative Recovery in Surgical Neonates and Dimethylarginine:Arginine Levels
Phase N/A · 2 location(s) · Liverpool Women's NHS Foundation Trust · NCT06731855An Exploratory Study of Arginine Supplementation and the Postoperative Immune REsponse
NA · 2 location(s) · University of Liverpool · NCT05306925Arginine Replacement Therapy in COVID-19
Phase 2 · 1 location(s) · Emory University · NCT05855330Comparative Efficacy of Different Dentin Occluding Toothpaste Technologies
Phase 3 · 1 location(s) · Colgate Palmolive · NCT07664592Study of ADI-PEG 20 Versus Placebo in Subjects With NASH
Phase 2 · 10 location(s) · Polaris Group · NCT05842512Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
Phase 1/Phase 2 · 2 location(s) · Emory University · NCT02447874Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Phase 1 · 1 location(s) · Elizabeth Austen Lawson · NCT04789148Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
EARLY_Phase 1 · 1 location(s) · Emory University · NCT06328686Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication
Phase N/A · 12 location(s) · Jamil Cedeño Mora · NCT07255378AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Phase 1/Phase 2 · 37 location(s) · AstraZeneca · NCT06137144Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients
Phase 2 · 1 location(s) · German University in Cairo · NCT07338682L-arginine for Knee Osteoarthritis Patients
NA · 1 location(s) · Xiangya Hospital of Central South University · NCT06054633L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
NA · 1 location(s) · Liverpool School of Tropical Medicine · NCT05934318Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment
NA · 3 location(s) · Pharmanutra S.p.a. · NCT07393360Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia Syndrome
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT07569861Comparison Between Treatments of Oligohydramnios
Phase 2 · 2 location(s) · Kafrelsheikh University · NCT07135037Arginine Metabolism in Youth With Type 2 Diabetes
NA · 1 location(s) · Baylor College of Medicine · NCT05477134Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS)
Phase 1 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06280482Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Var
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06085729Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT07276152Vasopressin and Pain Perception in the Brain
Phase 1/Phase 2 · 1 location(s) · University of Maryland, Baltimore · NCT03446456Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients
NA · 1 location(s) · Immedica Pharma US Inc · NCT07573059Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Control
Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT06808516A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Partici
Phase 1 · 3 location(s) · Bristol-Myers Squibb · NCT06672523Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT06821802Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patient
Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT06676774A Clinical Study of PA5 in Patients With Advanced Solid Tumors
Phase 1 · 2 location(s) · Chongqing Peg-Bio Biopharm Co., Ltd. · NCT07702162Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06344442Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease
EARLY_Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT07568509
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.